COMP <GO>
CNC vs ABBV // GROSS PROFIT MARGIN
Centene Corporation (NYSE) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: CNC 4
— ABBV 10
▲ GROSS PROFIT MARGIN LEADER: ABBV
LAST: $68.45 (-0.25%) • MKT CAP: $33.97B
gross-margins
8.10%
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
gross-margins
70.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNC VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CNC | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 8.10% | 70.20% | -62.10 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -31.00% | 29.00% | -60.00 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 33.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 12.72% | 3.47% | +9.25 | CNC | /fcf-yield <GO> |
| Operating Margin | -4.40% | 24.60% | -29.00 | ABBV | /operating-margins <GO> |
| Net Profit Margin | -3.80% | 6.90% | -10.70 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 20.00% | 8.60% | +11.40 | CNC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.52 | 5.33 | -2.81 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 7.40% | -0.70 | CNC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.4 | 72.8 | -19.43 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 1.15 | -0.21 | ABBV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.0x | 113.1x | -77.10 | CNC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $33.97B | $513.86B | -$479.89B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CNC REV | ABBV REV | CNC GROSS % | ABBV GROSS % | CNC FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $174.58B | $61.16B | 8.1% | 70.2% | $4.32B | $17.82B |
| FY 2024 | $145.50B | $56.33B | 11.7% | 70.0% | -$490.0M | $17.83B |
| FY 2023 | $140.09B | $54.32B | 44.0% | 44.0% | $1.75B | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNC // BETA 0.94
ABBV // BETA 1.15